Rubedo Life Sciences

top of page

RBC Global Healthcare Conference: Rubedo Life Sciences is the first company to be in the clinic with an GPX4 modulator. They are announcing data today for the first time in actinic keratosis

CEO Frederick Beddingfield says they saw a 46% reduction in the AK count in 4 weeks in the first 18 actinic keratosis patients evaluated. He describes the science and what is next.

Company News

5 hours ago

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page

RBC Global Healthcare Conference: Rubedo Life Sciences is the first company to be in the clinic with an GPX4 modulator. They are announcing data today for the first time in actinic keratosis

Follow BiotechTV

Sponsors

Sponsor Spotlight